Reductions in HbA1c were less pronounced than those in SURPASS-2, where mean changes from baseline in HbA1c were: 2.01% for 5 mg, 2.24% for 10 mg, 2.30% for 15 mg tirzepatide, and 1.86% for 1 mg semaglutide
Patients and clinicians should rely on trial protocols, emerging peer-reviewed literature, and open communication with the supervising medical team to navigate and manage any skin-related concerns safely
These treatments may kill cancer cells or stop them from growing
Post-marketing reports of hair shedding have been submitted for some incretin-based medicines
Our guide on pregnancy and tirzepatide covers this important topic in depth
Journaling: If you are not sure about the time or day you want to schedule for semaglutide administration, journaling is the way to go